{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:29:33Z","timestamp":1781522973771,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Smart Labs Group","award":["No Number"],"award-info":[{"award-number":["No Number"]}]},{"name":"University of Petra.","award":["No Number"],"award-info":[{"award-number":["No Number"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s40261-022-01191-1","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T20:18:48Z","timestamp":1661285928000},"page":"813-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan"],"prefix":"10.1007","volume":"42","author":[{"given":"Derar H.","family":"Abdel-Qader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Abdel-Qader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Silverthorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuenjid","family":"Kongkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Z.","family":"Al Meslamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wail","family":"Hayajneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama M. Abu","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Shnaigat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"AbuRuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad","family":"Al Nsour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Alhariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoun","family":"Shnewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Da\u2019ssan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathir M.","family":"Obeidat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoon E.","family":"Nusair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mothafer S.","family":"Jalamdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feras","family":"Hawari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoun","family":"Khader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima A.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Al Qudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Asad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"issue":"2","key":"1191_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc2104974","volume":"385","author":"LJ Abu-Raddad","year":"2021","unstructured":"Abu-Raddad LJ, Chemaitelly H, Butt AA. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N Engl J Med. 2021;385(2):187\u20139. https:\/\/doi.org\/10.1056\/NEJMc2104974.","journal-title":"N Engl J Med"},{"key":"1191_CR2","unstructured":"World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. 2021. https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Accessed 18 Feb 2022."},{"key":"1191_CR3","unstructured":"World Health Organization. Adverse Events Following Immunization (AEFI). 2020. https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and-safety\/pharmacovigilance\/health-professionals-info\/aefi. Accessed 21 Apr 2022."},{"issue":"7","key":"1191_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939\u201349. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3.","journal-title":"Lancet Infect Dis"},{"issue":"27","key":"1191_CR5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"key":"1191_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385:1078\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2110475.","journal-title":"N Engl J Med"},{"issue":"8","key":"1191_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","volume":"70","author":"J Gee","year":"2021","unstructured":"Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T, et al. First month of COVID-19 vaccine safety monitoring\u2014United States, December 14, 2020\u2013January 13, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(8):283\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1191_CR8","unstructured":"Reuters. COVID-19 Tracker\u2014Jordan. https:\/\/graphics.reuters.com\/world-coronavirus-tracker-and-maps\/countries-and-territories\/jordan\/. Accessed 31 Jul 2022."},{"issue":"2","key":"1191_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S2213-2600(21)00409-4","volume":"10","author":"S Toback","year":"2022","unstructured":"Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022;10(2):167\u201379. https:\/\/doi.org\/10.1016\/S2213-2600(21)00409-4.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"1191_CR10","first-page":"E13","volume":"58","author":"GL D\u2019al\u00f2","year":"2017","unstructured":"D\u2019al\u00f2 GL, Zorzoli E, Capanna A, Gervasi G, Terracciano E, Zaratti L, et al. Frequently asked questions on seven rare adverse events following immunization. J Prev Med Hyg. 2017;58(1):E13-26.","journal-title":"J Prev Med Hyg"},{"issue":"9","key":"1191_CR11","first-page":"2229","volume":"49","author":"SC Hartwig","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229\u201332.","journal-title":"Am J Hosp Pharm"},{"issue":"10275","key":"1191_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","volume":"397","author":"DY Logunov","year":"2021","unstructured":"Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671\u201381. https:\/\/doi.org\/10.1016\/S0140-6736(21)00234-8.","journal-title":"Lancet"},{"issue":"25","key":"1191_CR13","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","volume":"385","author":"AR Falsey","year":"2021","unstructured":"Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, et al. Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine. N Engl J Med. 2021;385(25):2348\u201360. https:\/\/doi.org\/10.1056\/NEJMoa2105290.","journal-title":"N Engl J Med"},{"issue":"2","key":"1191_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1473-3099(21)00462-X","volume":"22","author":"S Xia","year":"2022","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1\/2 trial. Lancet Infect Dis. 2022;22(2):196\u2013208. https:\/\/doi.org\/10.1016\/S1473-3099(21)00462-X.","journal-title":"Lancet Infect Dis"},{"key":"1191_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.urology.2021.04.002","volume":"153","author":"H Zhao","year":"2021","unstructured":"Zhao H, Souders C, Carmel M, Anger JT. Low rates of urologic side effects following coronavirus disease vaccination: an analysis of the food and drug administration vaccine adverse event reporting system. Urology. 2021;153:11\u20133.","journal-title":"Urology"},{"key":"1191_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41443-021-00483-y","volume":"34","author":"SP Lo","year":"2022","unstructured":"Lo SP, Hsieh T-C, Pastuszak AW, Hotaling JM, Patel DP. Effects of SARS CoV-2, COVID-19, and its vaccines on male sexual health and reproduction: where do we stand? Int J Impot Res. 2022;34:138\u201344. https:\/\/doi.org\/10.1038\/s41443-021-00483-y.","journal-title":"Int J Impot Res"},{"key":"1191_CR17","unstructured":"Centers for Disease Control and Prevention. Selected Adverse Events Reported after COVID-19 Vaccination. 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/adverse-events.html. Accessed 24 Dec 2021."},{"issue":"31","key":"1191_CR18","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.15585\/mmwr.mm7031e1","volume":"70","author":"AM Hause","year":"2021","unstructured":"Hause AM, Gee J, Baggs J, Abara WE, Marquez P, Thompson D, et al. COVID-19 vaccine safety in adolescents aged 12\u201317 years\u2014United States, December 14, 2020\u2013July 16, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(31):1053\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1191_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejim.2021.06.013","volume":"90","author":"M Zappa","year":"2021","unstructured":"Zappa M, Verdecchia P, Spanevello A, Visca D, Angeli F. Blood pressure increase after Pfizer\/BioNTech SARS-CoV-2 vaccine. Eur J Intern Med. 2021;90:111\u20133.","journal-title":"Eur J Intern Med"},{"key":"1191_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/25158163211044797","author":"DC Thunstedt","year":"2021","unstructured":"Thunstedt DC, Straube A, Sch\u00f6berl F. Isolated intracranial hypertension following COVID-19 vaccination: a case report. Cephalalgia Rep. 2021;4:1\u20133. https:\/\/doi.org\/10.1177\/25158163211044797.","journal-title":"Cephalalgia Rep."},{"issue":"11","key":"1191_CR21","doi-asserted-by":"publisher","first-page":"e743","DOI":"10.1016\/S2665-9913(21)00309-X","volume":"3","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Colafrancesco S, De Luca G, Rizzo N, Priori R, Conti F, et al. Cutaneous vasculitis following COVID-19 vaccination. Lancet Rheumatol. 2021;3(11):e743\u20134. https:\/\/doi.org\/10.1016\/S2665-9913(21)00309-X.","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"1191_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1186\/s12879-021-06655-x","volume":"21","author":"VT M\u00fccke","year":"2021","unstructured":"M\u00fccke VT, Knop V, M\u00fccke MM, Ochsendorf F, Zeuzem S. First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infect Dis. 2021;21(1):958. https:\/\/doi.org\/10.1186\/s12879-021-06655-x.","journal-title":"BMC Infect Dis"},{"key":"1191_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","volume":"78","author":"MT Shakoor","year":"2021","unstructured":"Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021;78:611\u20133.","journal-title":"Am J Kidney Dis"},{"key":"1191_CR24","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.2147\/JMDH.S331140","volume":"14","author":"Y Solomon","year":"2021","unstructured":"Solomon Y, Eshete T, Mekasha B, Assefa W. COVID-19 vaccine: side effects after the first dose of the oxford astrazeneca vaccine among health professionals in low-income country: Ethiopia. J Multidiscip Healthc. 2021;14:2577\u201385.","journal-title":"J Multidiscip Healthc"},{"issue":"10318","key":"1191_CR25","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/S0140-6736(21)02329-1","volume":"398","author":"R Lazarus","year":"2021","unstructured":"Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021;398(10318):2277\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(21)02329-1.","journal-title":"Lancet"},{"key":"1191_CR26","doi-asserted-by":"crossref","unstructured":"Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination. medRxiv. 2021. https:\/\/www.medrxiv.org\/content\/early\/2021\/07\/01\/2021.06.28.21258847. Accessed 17 Apr 2022.","DOI":"10.1101\/2021.06.28.21258847"},{"key":"1191_CR27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/IJGM.S310497","volume":"14","author":"NA El-Shitany","year":"2021","unstructured":"El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389\u2013401.","journal-title":"Int J Gen Med."},{"issue":"5","key":"1191_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","volume":"10","author":"SL Klein","year":"2010","unstructured":"Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338\u201349.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 3","key":"1191_CR29","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1093\/infdis\/jiu066","volume":"209","author":"SL Klein","year":"2014","unstructured":"Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;209(Suppl 3):S114\u20139.","journal-title":"J Infect Dis"},{"key":"1191_CR30","doi-asserted-by":"publisher","first-page":"100914","DOI":"10.1016\/j.eclinm.2021.100914","volume":"36","author":"A d\u2019Arminio Monforte","year":"2021","unstructured":"d\u2019Arminio Monforte A, Tavelli A, Perrone PM, Za A, Razzini K, Tomasoni D, et al. Association between previous infection with SARS CoV-2 and the risk of self-reported symptoms after mRNA BNT162b2 vaccination: data from 3,078 health care workers. EClinicalMedicine. 2021;36:100914. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100914.","journal-title":"EClinicalMedicine."},{"key":"1191_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1920273","author":"M Colaneri","year":"2022","unstructured":"Colaneri M, Di Benedetto A, Marvulli LN, Bocchio F, Cutti S, Marena C, et al. Are people previously infected with SARS-CoV-2 likely to experience COVID-19 symptoms again after vaccination? Results from an Italian COVID-19 referral center. Hum Vaccin Immunother. 2022;18(1):1920273. https:\/\/doi.org\/10.1080\/21645515.2021.1920273.","journal-title":"Hum Vaccin Immunother"},{"key":"1191_CR32","doi-asserted-by":"crossref","unstructured":"Younas M, Carrat F, Desaint C, Launay O, Corbeau P, Group for the AHV-BT. Immune activation, smoking, and vaccine response. AIDS. 2017;31(1):171\u20133. https:\/\/doi.org\/10.1097\/QAD.0000000000001311. Accessed 17 Apr 2022.","DOI":"10.1097\/QAD.0000000000001311"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01191-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-022-01191-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01191-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T18:19:50Z","timestamp":1664993990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-022-01191-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1007\/s40261-022-01191-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"3 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data are available upon reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"This study was funded by the Smart Labs Group and The Deanship of Scientific Research and Graduate Studies at the University of Petra.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Derar H. Abdel-Qader, Hasan Abdel-Qader, Jennifer Silverthorne, Chuenjid Kongkaew, Ahmad Z. Al Meslamani, Wail Hayajneh, Osama M. Abu Ata, Walid Shnaigat, Salah AbuRuz, Mohannad Al Nsour, Abdallah Alhariri, Khaldoun Shnewer, Mohammad Da\u2019ssan, Nathir M. Obeidat, Khaldoon E. Nusair, Mothafer S. Jalamdeh, Feras Hawari, Khaldoun Khader, Tareq Hakim, Fatima A. Hammad, Mustafa Al Qudah, and Mohammad Asad declare they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Research Committee of the Jordanian Ministry of Health (REC-MOH-7722).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"DAQ, HAQ, JS, CK, AZM: Concept development, study design, training of data collectors, data collection, project administration, methodology, data analysis, manuscript writing. WH, OAA, WS, SAR, MAN: Conceptualization, data collection, methodology, manuscript drafting. AA, KS, MD, NMO, KEN: Review and editing, methodology, supervision, data analysis. MSJ, FH, KK, TH, FA, MQ, MA: Data analysis, proofreading, editing, manuscript drafting, statistical procedures.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}